Oakridge International Limited (U9O0.F)
EUR 0.02
(-23.64%)
EUR 0.02
(-23.64%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -341.59 Thousand AUD | 32.5% |
| 2023 | -506.1 Thousand AUD | 68.52% |
| 2022 | -598.22 Thousand AUD | -174.96% |
| 2021 | 798.07 Thousand AUD | 2593.37% |
| 2020 | -32 Thousand AUD | 0.0% |
| 2019 | -32 Thousand AUD | 99.36% |
| 2018 | -5 Million AUD | 16.63% |
| 2017 | -5.99 Million AUD | -305.58% |
| 2016 | 2.91 Million AUD | 199.97% |
| 2015 | -2.91 Million AUD | -292.57% |
| 2014 | -743.64 Thousand AUD | 79.52% |
| 2013 | -3.63 Million AUD | 87.19% |
| 2012 | -28.34 Million AUD | -1390.44% |
| 2011 | -1.9 Million AUD | 49.6% |
| 2010 | -3.77 Million AUD | -79.13% |
| 2009 | -2.1 Million AUD | -23.89% |
| 2008 | -1.7 Million AUD | -218.73% |
| 2007 | -533.47 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -348.72 Thousand EUR | 0.0% |
| 2024 Q4 | -274.96 Thousand EUR | 0.0% |
| 2023 FY | -188.31 Thousand AUD | 68.52% |
| 2023 Q4 | -120.2 Thousand EUR | 38.94% |
| 2023 Q2 | -196.87 Thousand EUR | -15.38% |
| 2022 Q2 | -251.82 Thousand EUR | -33.02% |
| 2022 Q4 | -170.63 Thousand EUR | 32.24% |
| 2022 FY | -598.22 Thousand AUD | -174.96% |
| 2021 FY | 798.07 Thousand AUD | 2593.37% |
| 2021 Q4 | -189.31 Thousand EUR | 20.5% |
| 2021 Q2 | -238.12 Thousand EUR | -0.22% |
| 2020 Q2 | -663.1 Thousand EUR | 18.28% |
| 2020 Q4 | -237.61 Thousand EUR | 64.17% |
| 2020 FY | -32 Thousand AUD | 0.0% |
| 2019 Q4 | -811.44 Thousand EUR | 0.0% |
| 2019 FY | -32 Thousand AUD | 99.36% |
| 2018 FY | -5 Million AUD | 16.63% |
| 2017 FY | -5.99 Million AUD | -305.58% |
| 2016 FY | 2.91 Million AUD | 199.97% |
| 2015 FY | -2.91 Million AUD | -292.57% |
| 2014 FY | -743.64 Thousand AUD | 79.52% |
| 2013 FY | -3.63 Million AUD | 87.19% |
| 2012 FY | -28.34 Million AUD | -1390.44% |
| 2011 FY | -1.9 Million AUD | 49.6% |
| 2010 FY | -3.77 Million AUD | -79.13% |
| 2009 FY | -2.1 Million AUD | -23.89% |
| 2008 FY | -1.7 Million AUD | -218.73% |
| 2007 FY | -533.47 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| DocCheck AG | 3.54 Million EUR | 109.643% |
| CompuGroup Medical SE & Co. KGaA | 155.16 Million EUR | 100.22% |
| MeVis Medical Solutions AG | 6.44 Million EUR | 105.301% |
| Nexus AG | 24.76 Million EUR | 101.379% |